Lotus Pharmaceutical Executive and Leadership Team

Sharon Foo, the PA To Chief Executive Officer at Lotus Pharmaceutical, manages high-level administrative workflows and coordinates strategic communications for the executive office. By streamlining internal processes, the PA To Chief Executive Officer ensures the leadership team maintains focus on core pharmaceutical development goals. Sharon Foo facilitates critical interactions between the executive suite and departmental heads, fostering organizational alignment across the company's Asian manufacturing facilities. This role involves prioritizing complex scheduling demands and optimizing information flow to support rapid decision-making in the competitive generic medicine sector. Through meticulous oversight of executive priorities, the PA To Chief Executive Officer enables the seamless execution of corporate initiatives. Maintaining rigorous standards for operational efficiency, the office supports the broader mission of delivering specialty medicines to global markets. Ultimately, the position secures the stability of executive operations while advancing the company's commitment to accessible healthcare solutions.

Eeling Chan, the Chief Financial Officer at Lotus Pharmaceutical, directs the financial planning, reporting, and capital allocation strategies necessary for sustaining global pharmaceutical growth. Overseeing fiscal health, the Chief Financial Officer monitors budgetary performance across research and manufacturing divisions to ensure alignment with long-term profitability targets. Eeling Chan manages investor relations and regulatory financial compliance, providing the transparency required for international market expansion. By analyzing market trends in oncology and cardiovascular medicine, the Chief Financial Officer identifies investment opportunities that strengthen the company's competitive position. This leadership role involves collaborating with the Board to optimize resource distribution and mitigate financial risks associated with drug development cycles. Through disciplined fiscal management, the Chief Financial Officer supports the company's objective of providing affordable healthcare. Ultimately, the position drives the financial sustainability required to scale manufacturing operations and deliver high-quality specialty treatments to diverse patient populations worldwide.

Bjartur Shen, the Group Chief Financial Officer at Lotus Pharmaceutical, architects the overarching financial framework for the entire corporate group, focusing on consolidated reporting and cross-regional fiscal integration. By harmonizing financial policies across various Asian manufacturing sites, the Group Chief Financial Officer ensures consistent performance metrics and operational efficiency. Bjartur Shen evaluates large-scale capital investments and manages the group's liquidity to support the commercialization of generic and specialty medicines. This leadership role involves coordinating with regional finance teams to optimize tax structures and manage currency exposure in global markets. Through strategic oversight of the group's balance sheet, the Group Chief Financial Officer enables the company to pursue aggressive growth in central nervous system conditions and other therapeutic areas. By maintaining robust financial controls, the position supports the company's mission of improving healthcare access. Ultimately, the role secures the group's financial foundation for long-term innovation and market leadership.

Vamsi Kosaraju, the Chief Operations Officer & Chief Operating Officer at Lotus Pharmaceutical, directs the end-to-end manufacturing and supply chain logistics required to deliver specialty medicines globally. Overseeing production facilities across Asia, the Chief Operations Officer & Chief Operating Officer optimizes manufacturing throughput and quality control standards to meet international regulatory requirements. Vamsi Kosaraju manages the integration of research outputs into scalable commercial production, ensuring the efficient delivery of oncology and cardiovascular treatments. This leadership role involves streamlining operational workflows to reduce costs and improve product availability for patients. By coordinating with cross-functional teams, the Chief Operations Officer & Chief Operating Officer drives continuous improvement in manufacturing processes and facility safety. Through rigorous operational oversight, the position supports the company's commitment to affordable healthcare. Ultimately, the role ensures the reliability and scalability of the company's supply chain, directly impacting the ability to serve diverse global markets effectively.